Sign in
4/A

Changes in Ownership

Cytosorbents Corp Filed Acc 0001144204-14-046418

Director sold 50,000 shares at $0.24 ($11,830)

  • Director acquired 50,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Kraus Al Director 2014-07-14 Option exercise +50,000 $0.04 $1,750 1,443,631 D
Kraus Al Director 2014-07-14 Sale −50,000 $0.24 $11,830 1,393,631 D
Derivatives
Kraus Al Director 2014-07-14 Option exercise · Stock Option −50,000 6,869,328 D
Open-market sales · 50,000 sh · avg $0.24 · $11,830
Loading xslF345X03/v385449_4a.xml…